Open access · CC-BY
via OpenAlex
Cannabinoids and healthy ageing: the potential for extending healthspan and lifespan in preclinical models with an emphasis on Caenorhabditis elegans
Zhizhen Wang, Jonathon Carl Arnold
GeroScience · 2024 · ▲ 8 citations
Abstract
There is a significant global upsurge in the number and proportion of older persons in the population. With this comes an increasing prevalence of age-related conditions which pose a major challenge to healthcare systems. The development of anti-ageing treatments may help meet this challenge by targeting the ageing process which is a common denominator to many health problems. Cannabis-like compounds (cannabinoids) are reported to improve quality of life and general well-being in human trials, and there is increasing preclinical research highlighting that they have anti-ageing activity. Moreover, preclinical evidence suggests that endogenous cannabinoids regulate ageing processes. Here, we review the anti-ageing effects of the cannabinoids in various model systems, including the most extensively studied nematode model, Caenorhabditis elegans. These studies highlight that the cannabinoids lengthen healthspan(definition) and lifespan, with emerging evidence that they may also hinder the development of cellular senescence(definition). The non-psychoactive cannabinoid cannabidiol (CBD) shows particular promise, with mechanistic studies demonstrating it may work through autophagy(definition) induction and activation of antioxidative systems. Furthermore, CBD improves healthspan parameters such as diminishing age-related behavioural dysfunction in models of both healthy and accelerated ageing. Translation into mammalian systems provides an important next step. Moreover, looking beyond CBD, future studies could probe the multitude of other cannabis constituents for their anti-ageing activity.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1007/s11357-024-01162-8
- Canonical
- link ↗
- Fetched
- 2026-10-30 MST
Cite this
APA
Wang, Z., & Arnold, J.C. (2024). Cannabinoids and healthy ageing: the potential for extending healthspan and lifespan in preclinical models with an emphasis on Caenorhabditis elegans. <em>GeroScience</em>. https://doi.org/10.1007/s11357-024-01162-8
Vancouver
Wang Z, Arnold JC. Cannabinoids and healthy ageing: the potential for extending healthspan and lifespan in preclinical models with an emphasis on Caenorhabditis elegans. GeroScience. 2024. doi:10.1007/s11357-024-01162-8.
BibTeX
@article{zhizhen2024Cannab,
title = {Cannabinoids and healthy ageing: the potential for extending healthspan and lifespan in preclinical models with an emphasis on Caenorhabditis elegans},
author = {Zhizhen Wang and Jonathon Carl Arnold},
journal = {GeroScience},
year = {2024},
doi = {10.1007/s11357-024-01162-8},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
EMBO Reports 2007
Open access · OA
A conserved Toll‐like receptor is required for Caenorhabditis elegans innate immunity
bioRxiv (Cold Spring Harbor Laboratory) 2023
Preprint · CC-BY
3-phenyllactic acid promotes healthspan through SKN-1/ATFS-1-mediated mitochondrial activation and stress resilience
Microorganisms 2026
Open access · CC-BY
Multi-Model Longevity Assays Reveal Lifespan- and Healthspan-Promoting Effects of Bacillus subtilis WTC019
Microorganisms 2026
Citation only
Multi-Model Longevity Assays Reveal Lifespan- and Healthspan-Promoting Effects of <i>Bacillus subtilis</i> WTC019.
Trends in Food Science & Technology. 2025
Citation only
Food-derived bioactive compounds targeting mitophagy: Emerging nutritional strategies against sarcopenia
The Journal of Physiology 2015
Open access · CC-BY